(Q42952186)

11 November 2017

title

Preclinical studies of methylthioadenosine for the treatment of multiple sclerosis (English)

1 reference

11 November 2017

0 references

4

1 reference

11 November 2017

B Moreno

1

1 reference

11 November 2017

B Fernandez-Diez

series ordinal

2

1 reference

11 November 2017

A Di Penta

series ordinal

3

1 reference

11 November 2017

language of work or name

1 reference

29 July 2010

1 reference

Multiple Sclerosis Journal

11 November 2017

published in

1 reference

11 November 2017

volume

16

1 reference

11 November 2017

issue

9

1 reference

11 November 2017

page(s)

1102-1108

1 reference

https://api.crossref.org/works/10.1177%2F1352458510375968

11 November 2017

1 reference

Methylthioadenosine reverses brain autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510375968

Inhibition of transmethylation down-regulates CD4 T cell activation and curtails development of autoimmunity in a model system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510375968

The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510375968

Innate and adaptive autoimmunity directed to the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510375968

A network analysis of the human T-cell activation gene network identifies JAGGED1 as a therapeutic target for autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510375968

Gamma-aminobutyric acid transporter 1 negatively regulates T cell-mediated immune responses and ameliorates autoimmune inflammation in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510375968

Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510375968

Effective combination of minocycline and interferon-beta in a model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510375968

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510375968

Toward the development of rational therapies in multiple sclerosis: what is on the horizon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510375968

Immunotherapy for neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510375968

21 January 2018

Identifiers

DOI

10.1177/1352458510375968

1 reference

11 November 2017

1 reference